The first monoclonal antibody in Canada indicated for the treatment of adult patients with polymyalgia rheumatica (PMR) Nearly tripled the remission rates (28.3% vs 10.3%) compared to placebo in adult… Read More
EMRELIS is the first and only treatment approved for previously treated advanced NSCLC patients with high c-Met protein overexpression who often face poor prognosis and have limited treatment options Lung… Read More
AbCellera anticipates starting the Phase 1 clinical trial for ABCL635 in Q3 2025 VANCOUVER, BC – AbCellera (Nasdaq: ABCL) announced it has received a No Objection Letter (NOL) from Health… Read More
Collaboration to leverage AbbVie’s expertise in biotherapeutic drug development and commercialization together with ADARx’s proprietary RNA technology to advance next-generation siRNA therapies across neuroscience, immunology and oncology NORTH CHICAGO, ILL & SAN… Read More
CHARLOTTETOWN, PE – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is pleased to announce the appointment of Paula Casalino, P.Eng., Vice President, Operations – Canada at IPS Integrated… Read More
